Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of transdermal buprenorphine in children with cancer-related pain
2007-007042-35Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of buprenorphine in cancer pain, sponsored by Policlinico Gemelli. Primary endpoints: Effectiveness of transdermal buprenorphine and Tolerability of transdermal buprenorphine. Started Dec 2007; status: completed.
02
Drugs
buprenorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2007-007042-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007042-35.